Presentation TCT 2014 Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE Presenter: Fausto Feres September 16, 2014
Presentation TCT 2014 TCT 481: Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus-Eluting Stent Implantation in OPTIMIZE Presenter: Dietmar Trenk, Harvey D. White, Dominick J. Angiolillo, Fausto Feres September 14, 2014
Presentation ACC 2014 The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS) Presenter: M. Valgimigli March 31, 2014
Presentation TCT 2013 Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery Presenter: Masato Nakamura October 29, 2013
Presentation TCT 2013 The Evolution from Endeavor to Resolute: Stent Design Considerations and Results Presenter: David Kandzari October 28, 2013
Presentation TCT 2012 PROTECT: Three-Year Results of a Randomized Mega-Trial of Endeavor vs. Cypher Presenter: Edoardo Camenzind October 22, 2012
Presentation ESC 2012 Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial Presenter: William Wijns August 27, 2012